About this trial
A wireless and miniaturized vital sign (ECG, SpO2, Skin Temperature) sensor system, MicroPremVitals Button Sensors was developed by the Dr. John Rogers Laboratory (QSIB- Northwestern University, Chicago, USA) to facilitate vital sign monitoring in extremely preterm neonates.
Eligibility criteria
Qualifiers
Infants admitted to the NICU with a gestational age of ≥ 22+0 weeks and ≤ 29+6 weeks at birth,
AND >72h of age at time of study,
AND clinically stable,
AND with the Neonatal Nurse Practitioner (i.e., NNP) and Healthcare Team in agreement for the patient to participate in the study.
Disqualifiers
Infants with a skin abnormality that would potentially increase the risk of injury,
patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.
Infants admitted to the NICU with a gestational age of < 22+0 weeks or > 29+6 weeks at birth,
and/or ≤ 72h of age at time of study,
Trial design
Treatments tested in this trial
- Wireless MicroPremVitals Button Sensor System
Treatment groups
Sponsors and collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead sponsor
Northwestern Querrey Simpson Institute for Bioelectronics (QSIB)
Collaborator